The above evidence suggests that neurological damage in syphilis patients is associated with an increased CSF Th17/IL-17 response, and thus CSF IL-17 can be used to assess clinical outcomes of CNS syphilis treatment [71]. The gene discussed is IL17A; the disease is syphilis.